Mokhtech Meriem, Nurkic Sommer, Morris Christopher G, Mendenhall Nancy P, Mendenhall William M
a Department of Radiation Oncology , University of Florida College of Medicine , Gainesville , FL , USA.
Cancer Invest. 2018;36(6):330-337. doi: 10.1080/07357907.2018.1489550. Epub 2018 Aug 23.
To evaluate outcomes after definitive radiotherapy for orbital pseudotumor.
We reviewed adult patients treated between 1971 and 2012.
20 patients with 8.0-year median follow-up were analyzed. Symptoms improved in 75% of patients: 40% showed a complete response, 35% partial response, and 20% had stable disease. The disease progressed in 1 and recurred in 8 patients. Local control rates were 63% and 53% at 5 and 10 years, respectively. The most common toxicities were cataracts (10%) and dry eye (10%).
Radiotherapy for orbital pseudotumor is well-tolerated and results in long-term control in most patients, with local control in over half.
评估眼眶假瘤根治性放疗后的疗效。
我们回顾了1971年至2012年间接受治疗的成年患者。
分析了20例患者,中位随访时间为8.0年。75%的患者症状改善:40%完全缓解,35%部分缓解,20%病情稳定。1例疾病进展,8例复发。5年和10年的局部控制率分别为63%和53%。最常见的毒性反应是白内障(10%)和干眼(10%)。
眼眶假瘤放疗耐受性良好,大多数患者可获得长期控制,超过半数患者可实现局部控制。